GlassScriptPhysician profile
Amun Makani
NPI 1376705830
$3,486.56
in general payments reported to CMS, 2019-2025
14 companies · $984 in 2025
The $984 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $1,896 · 2021: $179 · 2022: $169 · 2023: $88.25 · 2024: $38.61 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.10 |
| Travel and Lodging | $488.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,624.40 | 2020-2025 | |
| Coastal Medical Technologies LLC | $225.85 | 2024-2025 | |
| Mvp Orthopedics INC | $177.56 | 2021-2023 | |
| Intuitive Surgical, INC. | $98.62 | 2022 | |
| Stryker Corporation | $69.94 | 2020-2023 | Mako |
| Depuy Synthes Sales INC. | $69.43 | 2020-2021 | |
| Horizon Therapeutics Plc | $69.13 | 2019 | |
| Ferring Pharmaceuticals INC. | $42.34 | 2019 | |
| Foundation Medicine, INC. | $29.24 | 2023 | Foundationone Liquid Cdx |
| Fidia Pharma USA INC. | $23.82 | 2020-2021 | |
| Pacira Therapeutics, INC. | $23.67 | 2020 | |
| Orthogenrx INC. | $20.59 | 2019 | |
| Electronic Waveform Lab, INC. | $11.97 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amun Makani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.